Utility of extended pattern prostate biopsies for tumor localization: Pathologic correlations after radical prostatectomy

Cancer

Volumn 113, Issue 7, 2008, Pages 1559-1565

  Schulte, Ryan T ^a   Wood, David P ^a   Daignault, Stephanie ^a   Shah, Rajal B ^a   Wei, John T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Focal therapy; Localization; Prostate biopsy; Prostate neoplasms

Indexed keywords

ARTICLE; CANCER INVASION; EVALUATION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PREDICTION AND FORECASTING; PROSTATE; PROSTATE TUMOR; PROSTATECTOMY; RISK;

BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 54049148177     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23781     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66. (Pubitemid 46148091)
2. Litwin MS, Gore JL, Kwan L, et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer. 2007;109:2239-2247. (Pubitemid 46801553)
3. Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23:2772-2780. (Pubitemid 46179467)
4. Bahn DK, Silverman P, Lee F Sr, Badalament R, Bahn ED, Rewcastle JC. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol. 2006;20:688-692. (Pubitemid 46140997)
5. Crawford ED, Barqawi A. Targeted focal therapy: a minimally invasive ablation technique for early prostate cancer. Oncology (Williston Park). 2007;21:27-32; discussion 33-24,39.
6. Onik G, Narayan P, Vaughan D, Dineen M, Brunelle R. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology. 2002;60:109-114. (Pubitemid 34722957)
7. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol. 2006;175:1605-1612.
8. Siu W, Dunn RL, Shah RB, Wei JT. Use of extended pattern technique for initial prostate biopsy. J Urol. 2005;174:505-509. (Pubitemid 40981585)
9. Descazeaud A, Rubin MA, Allory Y, et al. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?Eur Urol. 2005;48:911-915. (Pubitemid 41641634)
10. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Prostate Cancer Early Detection. Available at:http://www.nccn.org Accessed March 2008.
11. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142:71-74; discussion 74-75.
12. Babaian RJ, Toi A, Kamoi K, et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol. 2000;163:152-157.
13. Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol. 2000;163:158-162.
14. Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998;159:471-475; discussion 475-476.
15. Roehl KA, Antenor JA, Catalona WJ. Serial biopsy results in prostate cancer screening study. J Urol. 2002;167:2435-2439. (Pubitemid 34533140)
16. Emiliozzi P, Scarpone P, DePaula F, et al. The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/ml: a randomized study of 6 versus 12 core transperineal prostate biopsy. J Urol. 2004;171:197-199. (Pubitemid 37549122)
17. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol. 2000;164:388-392. (Pubitemid 30481932)
18. Gregori A, Vieweg J, Dahm P, Paulson DF. Comparison of ultrasound-guided biopsies and prostatectomy specimens: predictive accuracy of Gleason score and tumor site. Urol Int. 2001;66:66-71. (Pubitemid 32172970)
19. Scales CD, Amling CL, Kane CJ, et al. Can unilateral prostate cancer be reliably predicted based upon biopsy features? J Urol. 2006;175:373.
20. Boccon-Gibod LM, Dumonceau O, Toublanc M, Ravery V, Boccon-Gibod LA. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features. Eur Urol. 2005;48:895-899. (Pubitemid 41641631)
21. Raja J, Ramachandran N, Munneke G, Patel U. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. Clin Radiol. 2006;61:142-153. (Pubitemid 43137193)
22. Kravchick S, Cytron S, Peled R, Altshuler A, Ben-Dor D. Using gray-scale and 2 different techniques of color Doppler sonography to detect prostate cancer. Urology. 2003;61:977-981. (Pubitemid 36547742)
23. Lee BR, Roberts WW, Smith DG, et al. Bioimpedance: novel use of a minimally invasive technique for cancer localization in the intact prostate. Prostate. 1999;39:213-218. (Pubitemid 29203409)